Core Viewpoint - The company, Dengkang Oral Care, has shown a mixed performance in terms of financing activities and stockholder dynamics, with a notable increase in revenue and net profit year-on-year, indicating growth potential in the oral care market [1][2]. Financing Activities - On October 30, Dengkang Oral Care's stock price fell by 2.20%, with a trading volume of 65.24 million yuan. The financing buy-in amounted to 4.29 million yuan, while the financing repayment was 8.35 million yuan, resulting in a net financing outflow of 4.06 million yuan [1]. - As of October 30, the total financing and securities lending balance for Dengkang Oral Care was 40.99 million yuan, which represents 2.55% of its market capitalization. This financing balance is above the 80th percentile of the past year, indicating a high level of financing activity [1]. - The company had no securities lending activity on October 30, with a securities lending balance of 0.00 shares, which is below the 30th percentile of the past year, indicating low borrowing activity [1]. Financial Performance - For the period from January to September 2025, Dengkang Oral Care reported a revenue of 1.228 billion yuan, reflecting a year-on-year growth of 16.66%. The net profit attributable to shareholders was 136 million yuan, marking a 15.21% increase compared to the previous year [2]. - Since its A-share listing, Dengkang Oral Care has distributed a total of 344 million yuan in dividends [3]. Shareholder Dynamics - As of September 30, 2025, the number of shareholders for Dengkang Oral Care reached 10,600, an increase of 8.38% from the previous period. The average number of circulating shares per shareholder decreased by 7.73% to 4,069 shares [2]. - The top circulating shareholders include Tianhong Yongli Bond A, which holds 1.4526 million shares as the largest shareholder, and several other funds with varying changes in their holdings [3].
登康口腔10月30日获融资买入429.38万元，融资余额4098.97万元